Literature DB >> 22777942

Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.

Frédéric Bernard1, Caroline Moreau-Fauvarque, Céline Heitz-Marchaland, Yvrick Zagar, Laura Dumas, Stéphane Fouquet, Xinhua Lee, Zhaohui Shao, Sha Mi, Alain Chédotal.   

Abstract

Myelination is regulated by extracellular proteins, which control interactions between oligodendrocytes and axons. Semaphorins are repulsive axon guidance molecules, which control the migration of oligodendrocyte precursors during normal development and possibly in demyelinating diseases. We show here that the transmembrane semaphorin 6A (Sema6A) is highly expressed by myelinating oligodendrocytes in the postnatal mouse brain. In adult mice, Sema6A expression is upregulated in demyelinating lesions in cuprizone-treated mice. The analysis of the optic nerve and anterior commissure of Sema6A-deficient mice revealed a marked delay of oligodendrocyte differentiation. Accordingly, the development of the nodes of Ranvier is also transiently delayed. We also observed an arrest in the in vitro differentiation of purified oligodendrocytes lacking Sema6A, with a reduction of the expression level of Myelin Basic Protein. Their morphology is also abnormal, with less complex and ramified processes than wild-type oligodendrocytes. In myelinating co-cultures of dorsal root ganglion neurons and purified oligodendrocytes we found that myelination is perturbed in absence of Sema6A. These results suggest that Sema6A might have a role in myelination by controlling oligodendrocyte differentiation.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777942     DOI: 10.1002/glia.22378

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  15 in total

Review 1.  Semaphorins and plexins as therapeutic targets.

Authors:  Thomas Worzfeld; Stefan Offermanns
Journal:  Nat Rev Drug Discov       Date:  2014-08       Impact factor: 84.694

Review 2.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

Review 3.  Semaphorins and their Signaling Mechanisms.

Authors:  Laura Taylor Alto; Jonathan R Terman
Journal:  Methods Mol Biol       Date:  2017

4.  PKC induces release of a functional ectodomain of the guidance cue semaphorin6A.

Authors:  Riley M St Clair; Caroline M Dumas; Kori S Williams; Matthew T Goldstein; Elizabeth A Stant; Alicia M Ebert; Bryan A Ballif
Journal:  FEBS Lett       Date:  2019-08-16       Impact factor: 4.124

5.  Myocilin is involved in NgR1/Lingo-1-mediated oligodendrocyte differentiation and myelination of the optic nerve.

Authors:  Heung Sun Kwon; Naoki Nakaya; Mones Abu-Asab; Hong Sug Kim; Stanislav I Tomarev
Journal:  J Neurosci       Date:  2014-04-16       Impact factor: 6.167

Review 6.  Transmembrane semaphorins, forward and reverse signaling: have a look both ways.

Authors:  Chiara Battistini; Luca Tamagnone
Journal:  Cell Mol Life Sci       Date:  2016-01-21       Impact factor: 9.261

Review 7.  Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.

Authors:  Yueting Zhang; Taylor B Guo; Hongtao Lu
Journal:  Neurosci Bull       Date:  2013-04-05       Impact factor: 5.203

Review 8.  Transmembrane semaphorins: Multimodal signaling cues in development and cancer.

Authors:  Sreeharsha Gurrapu; Luca Tamagnone
Journal:  Cell Adh Migr       Date:  2016-06-13       Impact factor: 3.405

9.  Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.

Authors:  E M Medina-Rodríguez; F J Arenzana; J Pastor; M Redondo; V Palomo; R García de Sola; C Gil; A Martínez; A Bribián; F de Castro
Journal:  Cell Mol Life Sci       Date:  2013-05-10       Impact factor: 9.261

Review 10.  Myelin-based inhibitors of oligodendrocyte myelination: clues from axonal growth and regeneration.

Authors:  Feng Mei; S Y Christin Chong; Jonah R Chan
Journal:  Neurosci Bull       Date:  2013-03-20       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.